Davis Polk advised GeoPark Limited in the transaction. GeoPark Limited executed the offering of $150 million aggregate principal amount of its 5.500% senior notes due 2027....
You must be a Standard 1 Year member to access this content.
Davis Polk advised GeoPark Limited in the transaction. GeoPark Limited executed its cash tender offer for up to $255 million of its 6.500% senior notes due 2024....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the initial purchasers in the offering. GYP Holdings III Corp., a subsidiary of GMS, Inc., executed its offering of $350 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
You must be a Standard 1 Year member to access this content.
Barros & Errázuriz and Cleary Gottlieb Steen & Hamilton advised Inversiones CMPC. Davis Polk & Wardwell and Philippi Prietocarrizosa Ferrero DU & Uría advised the global...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Recursion Pharmaceuticals, Inc. executed its $500 million initial public offering of 27,878,787 shares of Class...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Uniti Group Inc. in the offering. Uniti Group Inc. executed a Rule 144A / Regulation S offering of $570 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT) announced the closing of its underwritten public offering...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Davis Polk & Wardwell, Skadden Arps Slate Meager & Flom, advised on the matter. Davis Polk & Wardwell advised Millicom International Cellular S.A. with...
You must be a Standard 1 Year member to access this content.
Davis Polk advised EnVen Energy Corporation, while Simpson Thacher advised the initial purchasers on the deal. EnVen Energy Corporation (“EnVen”) executed the offering of $300 million...
You must be a Standard 1 Year member to access this content.
